You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 807 A vaccine targeting the recurrent driver mutation H3K27M induces mutation specific T- and B- cell responses in patients with diffuse midline Gliomas

Article info

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
807 A vaccine targeting the recurrent driver mutation H3K27M induces mutation specific T- and B- cell responses in patients with diffuse midline Gliomas

Authors

  • Tamara Boschert German Cancer Research Center (DKFZ), Heidelberg, Germany Faculty of Biosciences, Heidelberg University, Heidelberg, Germany Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany Department of Neurology, Medical Faculty Mannheim, MCTN Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Taga Lerner BioMed X Innovation Center, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Kristina Kromer BioMed X Innovation Center, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Katharina Lindner DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Isabel Poschke German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Iris Mildenberger Department of Neurology, Medical Faculty Mannheim, MCTN Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Gordon Haltenhof German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Katharina Sahm DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • John Lindner BioMed X Innovation Center, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Edward Green German Cancer Research Center (DKFZ), Heidelberg, Germany Department of Neurology, Medical Faculty Mannheim, MCTN Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Michael Platten DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany Helmholtz Institute of Translational Oncology (HI-TRON), Mainz, Germany PubMed articlesGoogle scholar articles

Citation

Boschert T, Lerner T, Kromer K, et al
807 A vaccine targeting the recurrent driver mutation H3K27M induces mutation specific T- and B- cell responses in patients with diffuse midline Gliomas
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0807
Online issue publication 
November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.